메뉴 건너 뛰기
SinilPharm

Financial Information

BalanceSheet

Financial items 2017, 12 2016, 12 2015, 12
Price Composition Growth Price Composition Growth Price Composition Growth
TOTAL CURRENT ASSETS 48,131 45.9 ▼-10.5 53,787 54.9 ▲17.4 45,830 52.5 ▲1.3
TOTAL NON-CURRENT ASSETS 56,630 54.1 ▲27.9 44,266 45.1 ▲6.8 41,434 47.5 ▲19.5
TOTAL ASSETS 104,761 100 ▲6.8 98,053 100 ▲12.4 87,264 100 ▲9.2
TOTAL CURRENT LIABILITIES 7,813 7.5 ▲5.9 7,378 7.5 ▲5.2 7,016 8 ▼-14.5
TOTAL NON-CURRENT LIABILITIES 3,321 3.2 ▼-4.7 3,485 3.6 ▲68 2,074 2.4 ▲143.2
TOTAL LIABILITIES 11,135 10.6 ▲2.5 10,863 11.1 ▲19.5 9,091 10.4 ▲.4
Capital stocks 3,950 3.8 0 3,950 4 0 3,950 4.5 0
Capital surplus 2,671 2.5 0 2,671 2.7 0 2,671 3.1 0
Retained earnings 87,076 83.1 ▲8 80,640 82.2 ▲12.6 71,623 82.1 ▲11.3
TOTAL STOCKHOLDERS' EQUITY 93,626 89.4 ▲7.4 87,190 88.9 ▲11.5 78,173 89.6 ▲10.3

Income Statement

Financial items 2017, 12 2016, 12 2015, 12
Price Composition Growth Price Composition Growth Price Composition Growth
SALES(NET) 50,942 100 ▲1.5 50,212 100 ▲12.3 44,703 100 ▼-7.2
GROSS PROFIT 22,571 44.3 ▼-5.4 23,847 47.5 ▲8.1 22,055 49.3 ▼-9.2
OPERATING INCOME 9,261 18.2 ▼-18.4 11,348 22.6 ▲7.9 10,512 23.5 ▼-14.3
NON-OPERATING INCOME 710 1.4 ▲2.2 695 1.4 ▼-7.4 750 1.7 ▼-35.9
NON-OPERATING EXPENSES 1,249 2.5 ▲307.8 306 .6 ▼-57.3 717 1.6 ▼-34.8
NET INCOME 7,591 14.9 ▼-24.4 10,038 20 ▲14.5 8,764 19.6 ▼-13.9

Cash Flow Statement

Financial items 2017년 12월 2016년 12월 2015년 12월
Composition On changes Composition On changes Composition On changes
Cash flows from operating activities 8,951 ▲111.4 4,235 ▼-55.7 9,564 ▲2.5
Cash flows from investing activities -6,258 ▼-32.6 -4,720 ▲53.8 -10,217 ▼-25.8
CF from financing act. -968 ▲7.6 -1,049 ▼-82.7 -574 ▼-49.4
Increases(Decreases) in cash 1,725 ▲212.4 -1,534 ▼-25.1 -1,227 ▼-248.9
Cash at the beginning of the period 538 ▼-74 2,071 ▼-37.2 3,298 ▲33.3
Cash at the end of the period 2,262 ▲320.7 538 ▼-74 2,071 ▼-37.2